Oxenkrug G (2005). “Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implications”. 《Ann. N. Y. Acad. Sci.》 1053: 334–47. doi:10.1111/j.1749-6632.2005.tb00042.x. PMID16179540.
Gavazza MB.; Català A. (2004). “Protective effect of N-acetyl-serotonin on the nonenzymatic lipid peroxidation in rat testicular microsomes and mitochondria”. 《J. Pineal Res.》 37 (3): 153–60. doi:10.1111/j.1600-079x.2004.00150.x. PMID15357659.
Wölfler A.; Abuja PM.; Schauenstein K.; Liebmann PM. (1999). “N-acetylserotonin is a better extra- and intracellular antioxidant than melatonin”. 《FEBS Lett》 449 (2–3): 206–10. doi:10.1016/s0014-5793(99)00435-4. PMID10338133.
Oxenkrug G (2005). “Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implications”. 《Ann. N. Y. Acad. Sci.》 1053: 334–47. doi:10.1111/j.1749-6632.2005.tb00042.x. PMID16179540.
Gavazza MB.; Català A. (2004). “Protective effect of N-acetyl-serotonin on the nonenzymatic lipid peroxidation in rat testicular microsomes and mitochondria”. 《J. Pineal Res.》 37 (3): 153–60. doi:10.1111/j.1600-079x.2004.00150.x. PMID15357659.
Wölfler A.; Abuja PM.; Schauenstein K.; Liebmann PM. (1999). “N-acetylserotonin is a better extra- and intracellular antioxidant than melatonin”. 《FEBS Lett》 449 (2–3): 206–10. doi:10.1016/s0014-5793(99)00435-4. PMID10338133.
Perianayagam MC.; Oxenkrug GF.; Jaber BL. (2005). “Immune-modulating effects of melatonin, N-acetylserotonin, and N-acetyldopamine”. 《Ann. N. Y. Acad. Sci.》 1053: 386–93. doi:10.1111/j.1749-6632.2005.tb00046.x. PMID16179544.
Oxenkrug GF (1999). “Antidepressive and antihypertensive effects of MAO-A inhibition: role of N-acetylserotonin. A review”. 《Neurobiology (Budapest, Hungary)》 7 (2): 213–24. PMID10591054.
Oxenkrug GF (1997). “[N-acetylserotonin and hypotensive effect of MAO-A inhibitors]”. 《Voprosy Meditsinskoi Khimii》 (러시아어) 43 (6): 522–6. PMID9503569.